BioPharma News Archive

0

La Jolla Pharmaceutical Company Announces Proposed Underwritten Offering of Common Stock

La Jolla Pharmaceutical Company , a leader in the development of therapeutics targeting significant unmet life-threatening diseases, today announced its intention to offer and sell shares of its common stock in an underwritten offering pursuant to its existing shelf registration statement.
0

Pharmaceutical Market India 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and …

NEW YORK, July 22, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Pharmaceutical Market India 2014-2020, Formulations, Active Pharmaceutical ...
0

CTD Holdings Closes $1.725 Million Private Placement

CTD Holdings, Inc. , a manufacturer and distributor of cyclodextrins for the pharmaceutical, medical device, cosmetics, and other markets, announced today that it has closed on a Private Placement with ...
0

Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS …

EVANSTON, Ill., July 22, 2014 /PRNewswire/ -- The steady decline of pharmaceutical sales representative access to physicians is spreading to previously rep-friendly specialties, according to the spring 2014 AccessMonitor™ report from global sales and marketing consulting firm ZS Associates.      The report examines how often approximately 325,000 physicians and other prescribers meet with the ...
0

Iroko Pharmaceuticals Continues to Expand Commercialization of ZORVOLEX® With New Strategic Agreement in Latin America

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that its affiliate, Iroko Pharmaceuticals Inc., signed a licensing agreement with CALOX DE COSTA RICA S.A.
0

Research and Markets: Partnering Agreements with Sun Pharmaceutical 2009-2014

Research and Markets has announced the addition of the "Partnering Agreements with Sun Pharmaceutical 2009-2014" comp
0

Medicines360 and Actavis Announce FDA Acceptance for Filing of NDA for Levosert™ IUD

SAN FRANCISCO and DUBLIN, July 21, 2014 /PRNewswire/ -- Medicines360, a non-profit women's health pharmaceutical company, and Actavis plc (ACT), a leading global specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing Medicines360's New Drug Application (NDA) for Levosert™ (levonorgestrel), a hormonal intrauterine contraceptive ...
0

Research and Markets: India Pharmaceutical Market 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs …

Research and Markets has announced the addition of the "Pharmaceutical Market India 2014-2020, Formulations, Acti
0

Clarus Therapeutics Expands Board of Directors With Appointment of Two Pharmaceutical Industry Veterans

NORTHBROOK, Ill. -- Clarus Therapeutics, Inc., a men's health specialty pharmaceutical company focused on the development and commercialization of REXTORO(R), an oral testosterone (T) replacement product, ...
0

Teva Completes Acquisition of Labrys: Opens Door to a Strong and Novel Migraine Prevention and Treatment Franchise …

Teva Pharmaceutical Industries Ltd.  today announced the successful completion of the acquisition of Labrys.
Page 1 of 39612345...102030...Last »